A comprehensive view of GlobalData Plc. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.
GlobalData: General Motors delivers 'very good' Q1 results, with huge boost from high-margin truck sales in North America; GM's sales mix is favorable, while transaction prices remain high and incentives activity in US is still pretty low
Published:
April 23, 2024
by MarketLine
|
GlobalData: Iced and speciality coffee drinks trend driven by millennials/Gen Z, who prefer on-the-go beverages with added functional benefits like instant caffeine boost; demand also growing for small pack sizes, such as single-serve instant coffee pods
Published:
April 18, 2024
by GlobalData Plc
|
GlobalData expects rigid plastics to grow at 2.6% CAGR from 2023 to 2026, but innovative materials and processes are helping food and beverage industry reduce plastic in product packaging; report highlights efforts by PepsiCo, Danone, Coca-Cola, Starbucks
Published:
April 18, 2024
by GlobalData Plc
|
GlobalData: Eli Lilly set to reshape pharmaceutical landscape with obesity and Alzheimer's treatments, Mounjaro and donanemab; both drugs poised to beat market expectations, with Mounjaro's sales poised to reach US$34B in 2029, more than double Wegovy's
Published:
April 17, 2024
by GlobalData Plc
|
GlobalData predicts GLP-1 drugs will redefine big pharma sales; Eli Lilly's diabetes drug, Mounjaro, is forecasted to generate US$34.0B by 2029, surpassing the entire 2023 portfolio of Lilly, with the Alzheimer's drug donanemab adding another US$5.0B
Published:
April 17, 2024
by FiercePharma
|
Ask us about our Transformation & Innovation market view